Mariangela Russo

Deregulation of the PI3K and KRAS signaling pathways in human cancer cells determines their response to everolimus.

Francesca Molinari, Takehiko Sasazuki, Josep Tabernero, 2010, The Journal of clinical investigation.

Blockade of EGFR and MEK Intercepts Heterogeneous Mechanisms of Acquired Resistance to Anti-EGFR Therapies in Colorectal Cancer

A. Bardelli, M. Buscarino, F. Di Nicolantonio, 2014, Science Translational Medicine.

The molecular landscape of colorectal cancer cell lines unveils clinically actionable kinase targets

Marco Beccuti, Francesca Cordero, Claudio Isella, 2015, Nature Communications.

Tumor Heterogeneity and Lesion-Specific Response to Targeted Therapy in Colorectal Cancer.

Mari Mino-Kenudson, Giorgio Corti, Mauro Truini, 2016, Cancer discovery.